Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel H3 receptor agonists show full agonist activity in vivo after oral dosing

Nov. 30, 2000

Imifuramine: synthesis of a novel histamine H3 receptor agonist

Nov. 30, 2000

All patients dosed in trial of long-acting inhaled formulation of albuterol for asthma

Nov. 30, 2000

Promising candidate for asthma, COPD therapy characterized by Pfizer researchers

Nov. 28, 2000

Roche's new antiinflammatory agents inhibit alpha4 integrin binding

Nov. 27, 2000

PDE4 inhibitor YM-976 is first to show dissociation between antiinflammatory activity and emesis

Nov. 23, 2000

Synthesis and use of new integrin antagonists in the therapy of asthma

Nov. 21, 2000

Initiation of phase II CF trial with tgAAV-CF announced

Nov. 21, 2000

FDA okays Discovery's phase II trial with Surfaxin

Nov. 21, 2000

Recent patent discloses novel compounds particularly useful for asthma and rhinitis

Nov. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...